Imaging of gliomas;Imagerie des gliomes

Cancer/Radiotherapie

Volumn 12, Issue 6-7, 2008, Pages 669-675

  Martin Duverneuil, N ^a   Guillevin, R ^a   Chiras, J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Gliomas; MRI; Perfusion; Spectroscopy

Indexed keywords

GADOLINIUM; KI 67 ANTIGEN;

ABSCESS; ANGIOGENESIS; ASTROCYTOMA; CHROMOSOME DELETION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE INFILTRATIVE GLIOMA; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; GLIOMA; HISTOPATHOLOGY; HUMAN; LYMPHOMA; METASTASIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; SPECTROSCOPY; TUMOR BIOPSY;

BRAIN ABSCESS; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; OLIGODENDROGLIOMA;

EID: 55649108851     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2008.07.017     Document Type: Short Survey

References (47)

1. Al-Okaili R.N., Krejza J., Wang S., Woo J.H., and Melhem E.R. Advanced MR Imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 26 (2006) S173-S189
2. Al-Okaili R.N., Krejza J., Woo J.H., Wolf R.L., O'Rourke D.M., Judy K.D., et al. Intraaxial brain masses: MR Imaging-based diagnostic strategy - initial experience. Radiology 243 (2007) 539-550
3. Baehring J.M., Vives K.P., and Bannykh S. Images in neuro-oncology: anaplastic pleomorphic xanthoastrocytoma. J Neurooncol 79 (2006) 151-152
4. Callot V., Galanaud D., Figarella-Branger D., Lefur Y., Metellus P., Nicoli F., et al. Correlations between MR and endothelial hyperplasia in low-grade gliomas. J Magn Reson Imaging 26 (2007) 52-60
5. Castillo M., Smith J.K., and Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomes. AJNR Am J Neuroradiol 21 (2000) 1645-1649
6. Cha S., Tihan T., Crawford F., Fischbein N.J., Chang S., Bollen A., et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 26 (2005) 266-273
7. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27 (2006) 475-487
8. Crespo-Rodriguez A., Smirniotopoulos J.G., and Rushing E.J. MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology 49 (2007) 307-315
9. Croteau D., Scarpace L., Hearshen D., Gutierrez J., Fisher J.L., Rock J.P., et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with intreated glioma. Neurosurgery 49 (2001) 823-829
10. Danchaivijitr N., Waldman A.D., Tozer D.J., Benton C.E., Brasil Caseiras G., et al. Low-grade gliomas: Do changes in rCBV measurements at longitudinal perfusion-weighted MR Imaging predict malignant transformation?. Radiology 247 (2008) 170-178
11. Di Costanzo A., Scarabino T., Trojsi F., Giannatempo G.M., Popolizio T., Catapano D., et al. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 48 (2006) 622-631
12. Di Costanzo A., Scarabino T., Trojsi F., Popolizio T., Catapano D., Giannatempo G.M., et al. Proton MR spectroscopy of cerebral gliomas at 3T: spatial heterogeneity, and tumor grade and extent. Eur Radiol 18 (2008) 1727-1735
13. Duffau H., and Capelle L. Les gliomes infiltrants de bas grade - comprendre leur histoire naturelle pour mieux les diagnostiquer. Neurologies 11 (2008) 93-100
14. Grand S., Kremer S., Tropres I., Pasteris C., Krainik A., Hoffmann D., et al. Spectroscopie 1H, perfusion, diffusion : quelle place pour ces techniques lors du diagnostic et du suivi des principales tumeurs cérébrales sus-tentorielles de l'adulte ?. Rev Neurol 162 (2006) 1204-1220
15. Guillevin R., Menuel C., Duffau H., Kujas M., Capelle L., Aubert A., et al. Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas. J Neurooncol 87 (2008) 181-187
16. Hakyemez B., Erdogan C., Ercan I., Ergin N., Uysal S., and Atahan S. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 60 (2005) 493-502
17. Hakyemez B., Erdogan C., Bolca N., Yildrim N., Gokalp G., and Parlak M. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 24 (2006) 817-824
18. Jenkinson M.D., du Plessis D.G., Smith T.S., Joyce K.A., Warnke P.C., and Walker C. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 129 (2006) 1884-1891
19. Koeller K.K., and Henry J.M. Superficial gliomas: radiologic-pathologic correlation. Radiographics 21 (2001) 1533-1556
20. Koeller K.K., and Rushing E.J. From the archives of the AFIP - oligodendroglioma and its variants: radiologic-pathologic correlation. Radiographics 25 (2005) 1669-1688
21. Law M., Cha S., Knopp E.A., Johnson G., Arnett J., and Litt A.W. High grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222 (2002) 715-721
22. Law M., Yang S., Wang H., Babb J.S., Johnson G., Cha S., et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24 (2003) 1989-1998
23. Law M., Oh S., Johnson G., Babb J.S., Zagzag D., Golfinos J., et al. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 58 (2006) 1099-1107
24. Law M., Oh S., Babb J.S., Wang E., Inglese M., Zagzag D., et al. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modelling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 27 (2006) 1975-1982
25. Law M., Young R.J., Babb J.S., Peccerelli N., Chheang S., Gruber M.L., et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247 (2008) 490-498
26. Lellouch-Tubiana A., Boddaert N., Bourgeois M., Fohlen M., Jouvet A., Delalande O., et al. Angiocentric neuroepithelial tumor (ANET): a new epilepsy-related clinicopathological entity with distinctive MRI. Brain Pathol 15 (2005) 281-286
27. Lev M.H., Ozsunar Y., Henson J.W., Rasheed A.A., Barest G.D., Harsh IV G.R., et al. Glial tumor grading and outcome predilection using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR 25 (2004) 214-221
28. Louis D.N., Ohgaki H., Wiestler O.D., and Canevee W.K. WHO classification of tumours of the central nervous system (2007), IARC, Lyon
29. Maia Jr. A.C., Malheiros S.M., da Rocha A.J., Stávale J.N., Guimarães I.F., Borges L.R., et al. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. J Neurosurg 101 (2004) 970-976
30. Maia Jr. A.C., Malheiros S.M., da Rocha A.J., da Silva C.J., Gabbai A.A., Ferraz F.A., et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 26 (2005) 777-783
31. McKnight T.R., Lamborn K.R., Love T.D., Berger M.S., Chang S., Dillon W.P., et al. Correlation of magnetic resonance spectroscopic and growth characteristics within grades II and III gliomas. J Neurosurg 106 (2007) 660-666
32. Megyesi J.F., Kachur E., Lee D.H., Zlatescu M.C., Betensky R.A., Forsyth P.A., et al. Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 10 (2004) 4303-4306
33. Naggara O., Brami-Zylberberg F., Rodrigo S., Raynal M., Meary E., Godon-Hardy S., et al. Imagerie des métastases intracrâniennes chez l'adulte. J Radiol 87 (2006) 792-806
34. Naugle D.K., Duncan T.D., and Grice G.P. Oligoastrocytoma. Radiographics 24 (2004) 598-600
35. Pallud J., Devaux B., Nataf F., Roux F.X., and Daumas-Duport C. Délimitation spatiale des oligodendrogiomes de bas grade. Neurochirurgie 51 (2005) 254-259
36. Pomper M.G., Passe T.J., Burger P.C., Scheithauer B.W., and Brat D.J. Chordoid glioma: a neoplasm unique to the hypothalamus and anterior third ventricle. AJNR Am J Neuroradiol 22 (2001) 464-469
37. Preusser M., Hoischen A., Novak K., Czech T., Prayer D., Hainfellner J.A., et al. Angiocentric glioma. Report of clinico-pathologic and genetic findings in 8 cases. Am J Surg Pathol 31 (2007) 1709-1718
38. Scott J.N., Brasher P.M.A., Sevick R.J., Rewcastle N.B., and Forsyth P.A. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59 (2002) 947-949
39. Schimitzu H., Kumabe T., Shirane R., and Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21 (2000) 659-665
40. Spampinato M.V., Smith J.K., Kwock L., Ewend M., Grimme J.D., Camacho D.L., et al. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR 188 (2007) 204-212
41. Tonami H., Kamehiro M., Oguchi M., Higashi K., Yamamoto I., Njima T., et al. Chordoid glioma of the third ventricle: CT and MR findings. J Comput Assist Tomogr 24 (2000) 336-338
42. Weber M.A., Zoubaa S., Schlieter M., Jüttler E., Huttner H.B., Geletneky K., et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology (2006) 1899-1906
43. White M.L., Zhang Y., Kirby P., and Ryken T.C. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomes?. AJNR Am J Neuroradiol 26 (2005) 784-790
44. Whitmore R.G., Krejza J., Kapoor G.S., Huse J., Woo J.H., Bloom S., et al. Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging. J Neurosurg 107 (2007) 600-609
45. Xu M., See S.J., Ng W.H., Arul E., Back M.F., Yeo T.T., et al. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 56 (2005) 919-926
46. Yamasaki F., Kurisu K., Satoh K., Arita K., Sugiyama K., Ohtaki M., et al. Apparent diffusion coefficient of human brain tumors at MR Imaging. Radiology 235 (2005) 985-991
47. Zonari P., Baraldi P., and Crisi G. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 49 (2007) 795-803